News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,124 Results
Type
Article (49847)
Company Profile (278)
Press Release (686999)
Multimedia
Podcasts (63)
Webinars (12)
Section
Business (212341)
Career Advice (2098)
Deals (36539)
Drug Delivery (104)
Drug Development (83644)
Employer Resources (173)
FDA (16988)
Job Trends (15724)
News (359355)
Policy (34704)
Tag
Academia (2782)
Accelerated approval (5)
Adcomms (23)
Allergies (88)
Alliances (51622)
ALS (96)
Alzheimer's disease (1441)
Antibody-drug conjugate (ADC) (134)
Approvals (16988)
Artificial intelligence (280)
Autoimmune disease (23)
Automation (16)
Bankruptcy (373)
Best Places to Work (12096)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (191)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (297)
Cancer (2348)
Cardiovascular disease (191)
Career advice (1762)
Career pathing (31)
CAR-T (155)
Cell therapy (436)
Cervical cancer (22)
Clinical research (67977)
Collaboration (875)
Company closure (1)
Compensation (554)
Complete response letters (21)
COVID-19 (2718)
CRISPR (43)
C-suite (261)
Cystic fibrosis (102)
Data (2300)
Decentralized trials (2)
Denatured (28)
Depression (51)
Diabetes (282)
Diagnostics (6588)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (97)
Earnings (88950)
Editorial (40)
Employer branding (21)
Employer resources (147)
Events (117564)
Executive appointments (752)
FDA (18353)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (783)
Gene editing (114)
Generative AI (25)
Gene therapy (316)
GLP-1 (766)
Government (4691)
Grass and pollen (4)
Guidances (108)
Healthcare (19904)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (30)
Infectious disease (2869)
Inflammatory bowel disease (148)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (97)
Interviews (320)
IPO (16885)
IRA (41)
Job creations (4047)
Job search strategy (1501)
Kidney cancer (10)
Labor market (40)
Layoffs (489)
Leadership (18)
Legal (8466)
Liver cancer (79)
Lung cancer (331)
Lymphoma (156)
Machine learning (8)
Management (58)
Manufacturing (326)
MASH (73)
Medical device (14387)
Medtech (14392)
Mergers & acquisitions (20221)
Metabolic disorders (735)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (102)
Neuropsychiatric disorders (31)
Neuroscience (2012)
NextGen: Class of 2025 (6911)
Non-profit (4740)
Now hiring (40)
Obesity (393)
Opinion (218)
Ovarian cancer (78)
Pain (95)
Pancreatic cancer (89)
Parkinson's disease (154)
Partnered (21)
Patents (242)
Patient recruitment (117)
Peanut (48)
People (60196)
Pharmaceutical (68)
Pharmacy benefit managers (20)
Phase I (21151)
Phase II (29870)
Phase III (22316)
Pipeline (1289)
Policy (146)
Postmarket research (2741)
Preclinical (9035)
Press Release (67)
Prostate cancer (110)
Psychedelics (32)
Radiopharmaceuticals (256)
Rare diseases (393)
Real estate (6304)
Recruiting (65)
Regulatory (23740)
Reports (46)
Research institute (2482)
Resumes & cover letters (359)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (77)
Series A (131)
Series B (90)
Service/supplier (13)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3833)
State (2)
Stomach cancer (14)
Supply chain (71)
Tariffs (45)
The Weekly (33)
Vaccines (735)
Venture capitalists (42)
Weight loss (264)
Women's health (38)
Worklife (16)
Date
Today (295)
Last 7 days (868)
Last 30 days (2954)
Last 365 days (33421)
2025 (11560)
2024 (36109)
2023 (41146)
2022 (52382)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (794)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (41042)
Australia (6759)
California (6330)
Canada (2053)
China (550)
Colorado (281)
Connecticut (292)
Delaware (157)
Europe (88980)
Florida (937)
Georgia (216)
Idaho (61)
Illinois (586)
India (26)
Indiana (320)
Iowa (11)
Japan (170)
Kansas (107)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (949)
Massachusetts (4773)
Michigan (230)
Minnesota (411)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (68)
New Jersey (1794)
New Mexico (29)
New York (1799)
North Carolina (1050)
North Dakota (8)
Northern California (2768)
Ohio (209)
Oklahoma (14)
Oregon (35)
Pennsylvania (1414)
Puerto Rico (12)
Rhode Island (35)
South America (1186)
South Carolina (26)
South Dakota (1)
Southern California (2375)
Tennessee (105)
Texas (947)
United States (24099)
Utah (189)
Virginia (155)
Washington D.C. (68)
Washington State (578)
West Virginia (3)
Wisconsin (58)
737,124 Results for "corvia medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards
December 23, 2024
·
2 min read
News
Corvia Medical Announces Three-Year Clinical Trial Results Confirming Significant and Durable Benefits of the Corvia Atrial Shunt in Heart Failure Patients
October 25, 2024
·
3 min read
Genetown
Newly Published Data in JAMA Cardiology Demonstrates Favorable Long-term Effects of the Corvia Atrial Shunt in Heart Failure Patients
Corvia Medical, Inc announced the publication in JAMA Cardiology of two-year echocardiographic data from its REDUCE LAP-HF II randomized clinical trial of the Corvia® Atrial Shunt, offering groundbreaking insight into the impact of a shunt on the heart.
May 7, 2024
·
2 min read
Drug Development
Corvia Medical Releases Two-year Clinical Trial Results Confirming Sustained Benefit and Safety of Its Atrial Shunt in Heart Failure Patients
Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, announced two-year results from its REDUCE LAP-HF II randomized clinical trial confirming safety and sustained efficacy of the Corvia® Atrial Shunt in properly selected heart failure patients with preserved or mildly reduced ejection fraction.
May 22, 2023
·
3 min read
Genetown
CORVIA MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN THE RESPONDER-HF CONFIRMATORY TRIAL
Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure (HF), announced the first patient has been randomized in RESPONDER-HF, a global confirmatory trial of the Corvia Atrial Shunt in heart failure patients with preserved (HFpEF) or mildly reduced (HFmrEF) ejection fraction.
December 6, 2022
·
4 min read
Press Releases
FDA Classifies Q’Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
April 18, 2025
·
4 min read
Press Releases
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
April 29, 2025
·
2 min read
Press Releases
Transverse Medical Inc. Announces Completion of Series B2 Capital Raise
April 29, 2025
·
2 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
April 30, 2025
·
1 min read
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
1 of 73,713
Next
